Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Duodenal adenocarcinoma with neuroendocrine features in a patient with acromegaly and thyroid papillary adenocarcinoma: a unique combination of endocrine neoplasia.

Kato K, Takeshita Y, Misu H, Ishikura K, Kakinoki K, Sawada-Kitamura S, Kaneko S, Takamura T.

Endocr J. 2012;59(9):791-6. Epub 2012 May 31.

2.

[Primary thyroid and breast cancers in a patient with pituitary adenoma and acromegaly].

Marova EI, Bazarova EN, Bronshteĭn MI, Rozhinskaia LIa, Karetnikov IuP.

Sov Med. 1983;(7):119-22. Russian. No abstract available.

PMID:
6137876
3.
4.

[Effective treatment with constant subcutaneous infusion of octreotide in a patient with acromegaly associated with diabetic pre-coma and diabetes insipidus].

Abe T, Ohguni S, Tanigawa K, Kato Y.

Nihon Naibunpi Gakkai Zasshi. 1994 Nov 20;70(9):1029-38. Japanese.

PMID:
7851621
5.

Desensitization to somatostatin analogue (Octreotide) observed in a patient with acromegaly.

Haraguchi K, Ohtaka M, Takazawa K, Endo T, Onaya T.

Endocr J. 1995 Apr;42(2):295-300.

6.

Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.

Plöckinger U, Quabbe HJ.

Acta Neurochir (Wien). 2005 May;147(5):485-93; discussion 493. Epub 2005 Apr 4.

PMID:
15806331
7.

Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection.

Mozas J, Ocón E, López de la Torre M, Suárez AM, Miranda JA, Herruzo AJ.

Int J Gynaecol Obstet. 1999 Apr;65(1):71-3.

PMID:
10390105
8.

Octreotide improved ventricular arrhythmia in an acromegalic patient.

Suyama K, Uchida D, Tanaka T, Saito J, Noguchi Y, Nakamura S, Tatsuno I, Saito Y, Saeki N.

Endocr J. 2000 Mar;47 Suppl:S73-5.

9.

Acromegaly and pheochromocytoma: report of a rare coexistence.

Sleilati GG, Kovacs KT, Honasoge M.

Endocr Pract. 2002 Jan-Feb;8(1):54-60.

PMID:
11939762
10.

Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma.

Sisson JC, Giordano TJ, Avram AM.

Thyroid. 2012 Apr;22(4):430-6. doi: 10.1089/thy.2011.0345. Epub 2012 Mar 2.

11.

Surgical management of pituitary adenomas.

Laws ER Jr.

Curr Probl Cancer. 1984 Feb;8(8):1-26.

PMID:
6145544
12.

Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR.

Resmini E, Murialdo G, Giusti M, Boschetti M, Minuto F, Ferone D.

J Endocrinol Invest. 2005 Feb;28(2):166-9.

PMID:
15887864
13.

Acromegaly with normal growth hormone levels: response to Sandostatin-LAR treatment.

Shimon I, Nass D, Hadani M.

Pituitary. 2000 May;2(4):289-94.

PMID:
11081151
14.

Acromegaly associated with multiple tumors.

Sekizawa N, Hayakawa E, Tsuchiya K, Yoshimoto T, Akashi T, Fujii T, Yamada S, Hirata Y.

Intern Med. 2009;48(15):1273-8. Epub 2009 Aug 3.

15.

Poorly-controlled acromegaly accompanied by subclinical adrenal Cushing's syndrome after surgery for multiple endocrine tumors.

Ishikawa M, Kato M, Sasaki H, Morii T, Fujita H, Kakei M, Narita T, Yamada Y.

Intern Med. 2015;54(6):617-20. doi: 10.2169/internalmedicine.54.2782. Epub 2015 Jan 15.

16.

Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with thyroid papillary adenocarcinoma.

Kishida M, Otsuka F, Kataoka H, Yokota K, Oishi T, Yamauchi T, Doihara H, Tamiya T, Mimura Y, Ogura T, Makino H.

Endocr J. 2000 Dec;47(6):731-8.

17.

Scalp hair loss caused by octreotide in a patient with acromegaly: a case report.

Nakauchi Y, Kumon Y, Yamasaki H, Tahara K, Kurisaka M, Hashimoto K.

Endocr J. 1995 Jun;42(3):385-9.

18.

Type 1 diabetes associated with asymptomatic acromegaly successfully treated with surgery after pregnancy: a case report.

Iwai H, Ito H, Ri S, Harada T, Hirota N, Yamauchi T, Miyatake T, Ohno Y, Aoki N.

Endocr J. 2005 Aug;52(4):413-20.

19.

A patient with acromegaly who showed remarkable improvement of hyperglycemia after treatment with octreotide.

Hirose T, Kuroda T, Otsuki M, Takagi M, Yamamoto H, Motomura T, Kurebayashi S, Miyashita Y, Koga M, Arita N, Hayakawa T, Kishimoto T, Kasayama S.

Intern Med. 1997 May;36(5):345-50.

20.

Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndromes. Surgical experience.

van Heerden JA, Kent RB 3rd, Sizemore GW, Grant CS, ReMine WH.

Arch Surg. 1983 May;118(5):533-6.

PMID:
6132593

Supplemental Content

Support Center